152 related articles for article (PubMed ID: 8943865)
1. CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia: a Children's Cancer Group study.
Uckun FM; Steinherz PG; Sather H; Trigg M; Arthur D; Tubergen D; Gaynon P; Reaman G
Blood; 1996 Dec; 88(11):4288-95. PubMed ID: 8943865
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and treatment outcome of children with biphenotypic CD2+ CD19+ acute lymphoblastic leukemia: a Children's Cancer Group study.
Uckun FM; Gaynon P; Sather H; Arthur D; Trigg M; Tubergen D; Nachman J; Steinherz P; Sensel MG; Reaman GR
Blood; 1997 Apr; 89(7):2488-93. PubMed ID: 9116293
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Shuster JJ; Falletta JM; Pullen DJ; Crist WM; Humphrey GB; Dowell BL; Wharam MD; Borowitz M
Blood; 1990 Jan; 75(1):166-73. PubMed ID: 1688495
[TBL] [Abstract][Full Text] [Related]
5. Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-cell acute lymphoblastic leukemia.
Dibenedetto SP; Lo Nigro L; Mayer SP; Rovera G; Schilirò G
Blood; 1997 Aug; 90(3):1226-32. PubMed ID: 9242556
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group study.
Uckun FM; Gaynon PS; Sensel MG; Nachman J; Trigg ME; Steinherz PG; Hutchinson R; Bostrom BC; Sather HN; Reaman GH
J Clin Oncol; 1997 Jun; 15(6):2214-21. PubMed ID: 9196133
[TBL] [Abstract][Full Text] [Related]
7. A classification based on T cell selection-related phenotypes identifies a subgroup of childhood T-ALL with favorable outcome in the COALL studies.
Niehues T; Kapaun P; Harms DO; Burdach S; Kramm C; Körholz D; Janka-Schaub G; Göbel U
Leukemia; 1999 Apr; 13(4):614-7. PubMed ID: 10214870
[TBL] [Abstract][Full Text] [Related]
8. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.
Thomas X; Archimbaud E; Charrin C; Magaud JP; Fiere D
Leukemia; 1995 Feb; 9(2):249-53. PubMed ID: 7532767
[TBL] [Abstract][Full Text] [Related]
9. Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: method and significance.
Dworzak MN; Fritsch G; Panzer-Grümayer ER; Mann G; Gadner H
Leuk Lymphoma; 2000 Jul; 38(3-4):295-308. PubMed ID: 10830736
[TBL] [Abstract][Full Text] [Related]
10. Improved clinical outcome for children with T-lineage acute lymphoblastic leukemia after contemporary chemotherapy: a Children's Cancer Group Study.
Uckun FM; Reaman G; Steinherez PG; Arthur DC; Sather H; Trigg M; Tubergen D; Gaynon P
Leuk Lymphoma; 1996 Dec; 24(1-2):57-70. PubMed ID: 9049962
[TBL] [Abstract][Full Text] [Related]
11. Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies.
Putti MC; Rondelli R; Cocito MG; Aricó M; Sainati L; Conter V; Guglielmi C; Cantú-Rajnoldi A; Consolini R; Pession A; Zanesco L; Masera G; Biondi A; Basso G
Blood; 1998 Aug; 92(3):795-801. PubMed ID: 9680347
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87.
Creutzig U; Harbott J; Sperling C; Ritter J; Zimmermann M; Löffler H; Riehm H; Schellong G; Ludwig WD
Blood; 1995 Oct; 86(8):3097-108. PubMed ID: 7579404
[TBL] [Abstract][Full Text] [Related]
13. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
Uckun FM; Stork L; Seibel N; Sarquis M; Bedros C; Sather H; Sensel M; Reaman GH; Gaynon PS
Clin Cancer Res; 2000 Aug; 6(8):3123-30. PubMed ID: 10955793
[TBL] [Abstract][Full Text] [Related]
14. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
[TBL] [Abstract][Full Text] [Related]
15. Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: a Children's Cancer Group Study.
Uckun FM; Yang Z; Sather H; Steinherz P; Nachman J; Bostrom B; Crotty L; Sarquis M; Ek O; Zeren T; Tubergen D; Reaman G; Gaynon P
Blood; 1997 May; 89(10):3769-77. PubMed ID: 9160683
[TBL] [Abstract][Full Text] [Related]
16. Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
Aricò M; Basso G; Mandelli F; Rizzari C; Colella R; Barisone E; Zanesco L; Rondelli R; Pession A; Masera G
Cancer; 1995 Apr; 75(7):1684-93. PubMed ID: 8826928
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Uckun FM; Sather H; Gaynon P; Arthur D; Nachman J; Sensel M; Steinherz P; Hutchinson R; Trigg M; Reaman G
Leuk Lymphoma; 1997 Nov; 27(5-6):445-57. PubMed ID: 9477126
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of T-lineage leukemic cell growth in SCID mice: a Children's Cancer Group study.
Uckun FM; Waurzyniak BJ; Sather HN; Sensel MG; Chelstrom L; Nachman J; Gaynon PS; Bostrom B; Ek O; Sarquis M; Steinherz PG; Reaman GH
Leuk Lymphoma; 1999 Feb; 32(5-6):475-87. PubMed ID: 10048420
[TBL] [Abstract][Full Text] [Related]
20. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
